Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.7.0.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - 6 months ended Apr. 30, 2017 - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Oct. 31, 2016 $ 10,153 $ 3 $ 123,417 $ (128,176) $ 5,397
Balance, shares at Oct. 31, 2016 7,374,454 2,782,963      
Conversion of Series A preferred stock to common stock $ (816) $ 1 815
Conversion of Series A preferred stock to common stock, shares (3,336,700) 613,423      
Conversion of Series B preferred stock to common stock $ (514) 514
Conversion of Series B preferred stock to common stock, shares (6,092) 101,540      
Conversion of Series C preferred stock to common stock $ (441) 441
Conversion of Series C preferred stock to common stock, shares (5,648) 96,346      
Conversion of Series D preferred stock to common stock $ (1,127) 1,127
Conversion of Series D preferred stock to common stock, shares (96,332) 160,551      
Issuance of Series E preferred stock for research and development intellectual property $ 104,693 104,693
Issuance of Series E preferred stock for research and development intellectual property, shares 7,050      
Proceeds from option exercises 588 588
Proceeds from option exercises, shares 121,698      
Warrant exchange to common stock 78 78
Warrant exchange to common stock, shares 56,250      
Stock-based compensation expense $ 1 8,623 8,624
Stock-based compensation expense, shares 1,031,000      
Shares issued for cash $ 1 2,277 2,278
Shares issued for cash, shares 759,333      
Net loss     (116,021) (116,021)
Balance at Apr. 30, 2017 $ 111,948 $ 6 $ 137,880 $ (244,197) $ 5,637
Balance, shares at Apr. 30, 2017 3,936,732 5,723,104